The pilot study found that patients with IPF who used a truncated version of Almee saw a 49% reduction in anxiety score – measured using the GAD-7 scale – over the course of four weeks' follow-up.

The GAD-7 scale is widely used in clinical practice as an assessment tool for anxiety; scoring ranges from 0 to 21, with four levels spanning minimal anxiety (0 to 4) to severe (15 to 21).

Severe depression symptoms, defined in the study as PHQ-9 scores of 20 or higher, were reported by 22% of patients, and severe anxiety symptoms, defined as GAD-7 scores of 15 or higher, were ...

For example, the GAD-7 mean score fell from 14.3 to 7.1 and the BDI mean score from 30.6 to 14.8. The study also showed that mindfulness was enhanced. The MAIA total score increased from 83.1 to ...

Although they did not specify a particular tool, the one commonly used is the GAD-7 scale. Last week, the organization force posted final recommendation statements on screening for anxiety, ...